HC Wainwright Reaffirmed “Buy” Rating for Lexicon Pharmaceuticals Inc. (LXRX) - DailyQuint

Community Financial News
HC Wainwright Reaffirmed “Buy” Rating for Lexicon Pharmaceuticals Inc. (LXRX)
DailyQuint
HC Wainwright reissued their buy rating on shares of Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) in a research note published on Wednesday. LXRX has been the subject of several other research reports. Cowen and Company reissued a hold rating on ...
HC Wainwright Reaffirms "Buy" Rating for Lexicon Pharmaceuticals Inc. (LXRX)Community Financial Newsall 2 news articles&